IGF1 and sarcoma: This study identified novel associations with circulating metabolic and endocrine biomarkers (such as insulin-like growth factor 1 (IGF-1), and lower sex hormone binding globulin), and reported novel associations between longer telomere length and increased sarcoma risk and endometriosis [130].